Clinical TrialCompleted

Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies

The purpose of the study aims to determine whether different concentrations of nitrous oxide (N2O) have different antidepressant effects for adults with treatment-resistant major depression.

Target Enrollment
Not specified
Study Type
Phase II interventional
Design
Randomized

Study Details

  • Status
    Completed
  • Phase
    Phase II
  • Type
    interventional
  • Design
    Randomized
  • Timeline
    Start: 2016-11-22
    End: 2020-02-18

Related Publications

A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression

Published
Authors
Nagele, P., Palanca, B. J., Gott, B., Brown, F., Barnes, L., Nguyen, T., Xiong, W., Salloum, N. C., Espejo, G. D., Lessov-Schlaggar, C. N., Jain, N., Cheng, W. W. L., Komen, H., Yee, B., Bolzenius, J. D., Janski, A., Gibbons, R., Zorumski, C. F., Conway, C. R.

Your Library

Inhaled Nitrous Oxide for Treatment-Resistant... — Clinical Trial Details | Blossom